Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global High Affinity Nerve Growth Factor Receptor Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global High Affinity Nerve Growth Factor Receptor Market Status and Forecast (2016-2027)
      • 1.3.2 Global High Affinity Nerve Growth Factor Receptor Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global High Affinity Nerve Growth Factor Receptor Supply by Company

    • 2.1 Global High Affinity Nerve Growth Factor Receptor Sales Volume by Company
    • 2.2 Global High Affinity Nerve Growth Factor Receptor Sales Value by Company
    • 2.3 Global High Affinity Nerve Growth Factor Receptor Price by Company
    • 2.4 High Affinity Nerve Growth Factor Receptor Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional High Affinity Nerve Growth Factor Receptor Market Status by Category

    • 3.1 High Affinity Nerve Growth Factor Receptor Category Introduction
      • 3.1.1 ASP-7962
      • 3.1.2 AZD-7451
      • 3.1.3 BNN-27
      • 3.1.4 Cenegermin
      • 3.1.5 CRB-0089
      • 3.1.6 Others
    • 3.2 Global High Affinity Nerve Growth Factor Receptor Market by Category
      • 3.2.1 Global High Affinity Nerve Growth Factor Receptor Sales Volume by Category (2016-2021)
      • 3.2.2 Global High Affinity Nerve Growth Factor Receptor Sales Value by Category (2016-2021)
      • 3.2.3 Global High Affinity Nerve Growth Factor Receptor Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional High Affinity Nerve Growth Factor Receptor Market Status by End User/Segment

    • 4.1 High Affinity Nerve Growth Factor Receptor Segment by End User/Segment
      • 4.1.1 Bile Duct Cancer
      • 4.1.2 Papillary Thyroid Cancer
      • 4.1.3 Low Back Pain
      • 4.1.4 Lung Cancer
      • 4.1.5 Others
    • 4.2 Global High Affinity Nerve Growth Factor Receptor Market by End User/Segment
      • 4.2.1 Global High Affinity Nerve Growth Factor Receptor Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global High Affinity Nerve Growth Factor Receptor Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global High Affinity Nerve Growth Factor Receptor Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global High Affinity Nerve Growth Factor Receptor Market Status by Region

    • 5.1 Global High Affinity Nerve Growth Factor Receptor Market by Region
      • 5.1.1 Global High Affinity Nerve Growth Factor Receptor Sales Volume by Region
      • 5.1.2 Global High Affinity Nerve Growth Factor Receptor Sales Value by Region
    • 5.2 North America High Affinity Nerve Growth Factor Receptor Market Status
    • 5.3 Europe High Affinity Nerve Growth Factor Receptor Market Status
    • 5.4 Asia Pacific High Affinity Nerve Growth Factor Receptor Market Status
    • 5.5 Central & South America High Affinity Nerve Growth Factor Receptor Market Status
    • 5.6 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Status

    6 North America High Affinity Nerve Growth Factor Receptor Market Status

    • 6.1 North America High Affinity Nerve Growth Factor Receptor Market by Country
      • 6.1.1 North America High Affinity Nerve Growth Factor Receptor Sales Volume by Country (2016-2021)
      • 6.1.2 North America High Affinity Nerve Growth Factor Receptor Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe High Affinity Nerve Growth Factor Receptor Market Status

    • 7.1 Europe High Affinity Nerve Growth Factor Receptor Market by Country
      • 7.1.1 Europe High Affinity Nerve Growth Factor Receptor Sales Volume by Country (2016-2021)
      • 7.1.2 Europe High Affinity Nerve Growth Factor Receptor Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific High Affinity Nerve Growth Factor Receptor Market Status

    • 8.1 Asia Pacific High Affinity Nerve Growth Factor Receptor Market by Country
      • 8.1.1 Asia Pacific High Affinity Nerve Growth Factor Receptor Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific High Affinity Nerve Growth Factor Receptor Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America High Affinity Nerve Growth Factor Receptor Market Status

    • 9.1 Central & South America High Affinity Nerve Growth Factor Receptor Market by Country
      • 9.1.1 Central & South America High Affinity Nerve Growth Factor Receptor Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America High Affinity Nerve Growth Factor Receptor Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Status

    • 10.1 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market by Country
      • 10.1.1 Middle East & Africa High Affinity Nerve Growth Factor Receptor Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa High Affinity Nerve Growth Factor Receptor Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 High Affinity Nerve Growth Factor Receptor Manufacturing Cost Analysis
    • 11.5 High Affinity Nerve Growth Factor Receptor Sales Channel and Distributors Analysis
      • 11.5.1 High Affinity Nerve Growth Factor Receptor Sales Channel
      • 11.5.2 High Affinity Nerve Growth Factor Receptor Distributors
    • 11.6 High Affinity Nerve Growth Factor Receptor Downstream Major Buyers

    12 Global High Affinity Nerve Growth Factor Receptor Market Forecast by Category and by End User/Segment

    • 12.1 Global High Affinity Nerve Growth Factor Receptor Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global High Affinity Nerve Growth Factor Receptor Forecast by Category
      • 12.2.1 Global High Affinity Nerve Growth Factor Receptor Sales Volume Forecast by Category
      • 12.2.2 Global High Affinity Nerve Growth Factor Receptor Sales Value Forecast by Category
      • 12.2.3 Global High Affinity Nerve Growth Factor Receptor Price Forecast by Category
    • 12.3 Global High Affinity Nerve Growth Factor Receptor Forecast by End User/Segment
      • 12.3.1 Global High Affinity Nerve Growth Factor Receptor Sales Volume Forecast by End User/Segment
      • 12.3.2 Global High Affinity Nerve Growth Factor Receptor Sales Value Forecast by End User/Segment
      • 12.3.3 Global High Affinity Nerve Growth Factor Receptor Price Forecast by End User/Segment

    13 Global High Affinity Nerve Growth Factor Receptor Market Forecast by Region/Country

    • 13.1 Global High Affinity Nerve Growth Factor Receptor Market Forecast by Region (2022-2027)
      • 13.1.1 Global High Affinity Nerve Growth Factor Receptor Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global High Affinity Nerve Growth Factor Receptor Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Tiziana Life Sciences Plc
      • 14.1.1 Company Information
      • 14.1.2 High Affinity Nerve Growth Factor Receptor Product Introduction
      • 14.1.3 Tiziana Life Sciences Plc High Affinity Nerve Growth Factor Receptor Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Sienna Biopharmaceuticals Inc
      • 14.2.1 Company Information
      • 14.2.2 High Affinity Nerve Growth Factor Receptor Product Introduction
      • 14.2.3 Sienna Biopharmaceuticals Inc High Affinity Nerve Growth Factor Receptor Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Rottapharm Biotech Srl
      • 14.3.1 Company Information
      • 14.3.2 High Affinity Nerve Growth Factor Receptor Product Introduction
      • 14.3.3 Rottapharm Biotech Srl High Affinity Nerve Growth Factor Receptor Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Proximagen Ltd
      • 14.4.1 Company Information
      • 14.4.2 High Affinity Nerve Growth Factor Receptor Product Introduction
      • 14.4.3 Proximagen Ltd High Affinity Nerve Growth Factor Receptor Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Plexxikon Inc
      • 14.5.1 Company Information
      • 14.5.2 High Affinity Nerve Growth Factor Receptor Product Introduction
      • 14.5.3 Plexxikon Inc High Affinity Nerve Growth Factor Receptor Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Nerviano Medical Sciences Srl
      • 14.6.1 Company Information
      • 14.6.2 High Affinity Nerve Growth Factor Receptor Product Introduction
      • 14.6.3 Nerviano Medical Sciences Srl High Affinity Nerve Growth Factor Receptor Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Merck & Co Inc
      • 14.7.1 Company Information
      • 14.7.2 High Affinity Nerve Growth Factor Receptor Product Introduction
      • 14.7.3 Merck & Co Inc High Affinity Nerve Growth Factor Receptor Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Loxo Oncology Inc
      • 14.8.1 Company Information
      • 14.8.2 High Affinity Nerve Growth Factor Receptor Product Introduction
      • 14.8.3 Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Ignyta Inc
      • 14.9.1 Company Information
      • 14.9.2 High Affinity Nerve Growth Factor Receptor Product Introduction
      • 14.9.3 Ignyta Inc High Affinity Nerve Growth Factor Receptor Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Handok Inc
      • 14.10.1 Company Information
      • 14.10.2 High Affinity Nerve Growth Factor Receptor Product Introduction
      • 14.10.3 Handok Inc High Affinity Nerve Growth Factor Receptor Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 SWOT Analysis
    • 14.11 Genzyme Corp
    • 14.12 Dompe Farmaceutici SpA
    • 14.13 Daiichi Sankyo Co Ltd
    • 14.14 AstraZeneca Plc
    • 14.15 Astellas Pharma Inc
    • 14.16 Array BioPharma Inc

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global High Affinity Nerve Growth Factor Receptor market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global High Affinity Nerve Growth Factor Receptor market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      ASP-7962
      AZD-7451
      BNN-27
      Cenegermin
      CRB-0089
      Others

      Segmented by End User/Segment
      Bile Duct Cancer
      Papillary Thyroid Cancer
      Low Back Pain
      Lung Cancer
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Tiziana Life Sciences Plc
      Sienna Biopharmaceuticals Inc
      Rottapharm Biotech Srl
      Proximagen Ltd
      Plexxikon Inc
      Nerviano Medical Sciences Srl
      Merck & Co Inc
      Loxo Oncology Inc
      Ignyta Inc
      Handok Inc
      Genzyme Corp
      Dompe Farmaceutici SpA
      Daiichi Sankyo Co Ltd
      AstraZeneca Plc
      Astellas Pharma Inc
      Array BioPharma Inc
      Buy now